APE/Ref-1 is increased in nuclear fractions of human thyroid hyperfunctioning nodules

Area of Science:

• Endocrinology
• Molecular Biology
• Cancer Research

Background:

• Apurinic/apyrimidinic endonuclease (APE/Ref-1) is a key protein involved in DNA repair, transcription regulation, and anti-apoptosis.
• Thyroid-stimulating hormone (TSH) regulates APE/Ref-1 synthesis and nuclear translocation in thyroid cells.
• Reduced nuclear APE/Ref-1 levels are observed in thyroid carcinoma tissues and cell lines.

Purpose of the Study:

• To investigate APE/Ref-1 expression and cellular localization in hyperfunctioning thyroid nodules.
• To determine if APE/Ref-1 nuclear translocation, observed in cell cultures, occurs in vivo in thyroid conditions.
• To explore the role of APE/Ref-1 in thyroid nodule development and its potential link to malignancy.

Main Methods:

• Western blot analysis was used to quantify APE/Ref-1 protein.
• Analysis was performed on hyperfunctioning thyroid nodules from patients with toxic adenoma and/or toxic multinodular goiter.
• Comparison was made between nodule tissue and adjacent normal thyroid tissue.

Main Results:

• The total content of APE/Ref-1 protein was elevated in most hyperfunctioning thyroid nodules compared to normal tissue.
• Nuclear levels of APE/Ref-1 were also increased in these nodules.
• Findings suggest enhanced cytoplasm-to-nucleus translocation and increased synthesis of APE/Ref-1 in vivo.

Conclusions:

• The study confirms in vivo nuclear translocation of APE/Ref-1 in hyperfunctioning thyroid nodules.
• Results suggest a two-stage model for APE/Ref-1 in thyroid cancer progression: upregulation in early hyperplasia, followed by a decrease in advanced, undifferentiated stages.
• APE/Ref-1 dynamics may serve as a biomarker for thyroid cell transformation and differentiation status.